Stocks
Medtronic Financial Statements (MDT) |
||||||||||
| Medtronicsmart-lab.ru | % | 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 23.06.2022 | 30.04.2023 | 22.06.2023 | 30.04.2024 | 20.06.2024 | 27.08.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 31 686 | 31 227 | 31 227 | 32 364 | 33 008 | ||||
| Operating Income, bln rub | 5 752 | 5 485 | 5 485 | 5 144 | 6 054 | |||||
| EBITDA, bln rub | ? | 9 554 | 9 042 | 8 475 | 9 056 | 9 111 | ||||
| Net profit, bln rub | ? | 5 039 | 3 758 | 3 758 | 3 676 | 3 393 | ||||
| OCF, bln rub | ? | 7 346 | 6 039 | 6 039 | 6 787 | 4 749 | ||||
| CAPEX, bln rub | ? | 1 368 | 1 459 | 1 459 | 1 587 | 1 466 | ||||
| FCF, bln rub | ? | 5 978 | 4 580 | 4 580 | 5 200 | 3 283 | ||||
| Dividend payout, bln rub | 3 383 | 3 616 | 3 616 | 3 666 | 2 709 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| Dividend payout ratio, % | 67.1% | 96.2% | 96.2% | 99.7% | 79.8% | |||||
| OPEX, bln rub | 15 633 | 14 678 | 14 678 | 16 129 | 14 699 | |||||
| Cost of production, bln rub | 10 145 | 10 719 | 10 719 | 12 911 | 12 706 | |||||
| R&D, bln rub | 2 746 | 2 696 | 2 696 | 2 735 | 2 702 | |||||
| Interest expenses, bln rub | 553.0 | 636.0 | 636.0 | 719.0 | 738.0 | |||||
| Assets, bln rub | 90 981 | 90 948 | 90 948 | 89 981 | 89 981 | 89 749 | ||||
| Net Assets, bln rub | ? | 52 551 | 51 483 | 51 483 | 50 214 | 50 214 | 47 947 | |||
| Debt, bln rub | 24 114 | 24 364 | 24 364 | 25 024 | 26 047 | 27 865 | ||||
| Cash, bln rub | 10 573 | 7 959 | 7 959 | 8 005 | 8 005 | 7 843 | ||||
| Net debt, bln rub | 13 541 | 16 405 | 16 405 | 17 019 | 18 042 | 20 022 | ||||
| Ordinary share price, rub | 104.4 | 91.0 | 91.0 | 80.2 | 79.7 | 72.0 | ||||
| Number of ordinary shares, mln | 1 342 | 1 330 | 1 330 | 1 328 | 1 293 | |||||
| Market cap, bln rub | 140 093 | 120 945 | 120 945 | 0 | 105 871 | 93 118 | ||||
| EV, bln rub | ? | 153 634 | 137 350 | 137 350 | 17 019 | 123 913 | 113 140 | |||
| Book value, bln rub | -3 546 | -4 786 | -4 786 | 9 228 | -3 997 | -5 956 | ||||
| EPS, rub | ? | 3.75 | 2.83 | 2.83 | 2.77 | 2.62 | ||||
| FCF/share, rub | 4.45 | 3.44 | 3.44 | 3.92 | 2.54 | |||||
| BV/share, rub | -2.64 | -3.60 | -3.60 | -3.01 | -4.61 | |||||
| EBITDA margin, % | ? | 30.2% | 29.0% | 27.1% | 28.0% | 27.6% | ||||
| Net margin, % | ? | 15.9% | 12.0% | 12.0% | 11.4% | 10.3% | ||||
| FCF yield, % | ? | 4.27% | 3.79% | 3.79% | 0.00% | 4.91% | 3.53% | |||
| ROE, % | ? | 9.59% | 7.30% | 7.30% | 0.00% | 7.32% | 7.08% | |||
| ROA, % | ? | 5.54% | 4.13% | 4.13% | 0.00% | 4.09% | 3.78% | |||
| P/E | ? | 27.8 | 32.2 | 32.2 | 28.8 | 27.4 | ||||
| P/FCF | 23.4 | 26.4 | 26.4 | 20.4 | 28.4 | |||||
| P/S | ? | 4.42 | 3.87 | 3.87 | 3.27 | 2.82 | ||||
| P/BV | ? | -39.5 | -25.3 | -25.3 | 0.00 | -26.5 | -15.6 | |||
| EV/EBITDA | ? | 16.1 | 15.2 | 16.2 | 13.7 | 12.4 | ||||
| Debt/EBITDA | 1.42 | 1.81 | 1.94 | 1.99 | 2.20 | |||||
| R&D/CAPEX, % | 200.7% | 184.8% | 184.8% | 172.3% | 184.3% | |||||
| CAPEX/Revenue, % | 4.32% | 4.67% | 4.67% | 4.90% | 4.44% | |||||
| Medtronic shareholders | ||||||||||
